Pfizer Inc (PFE)
Fixed asset turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 63,627,000 | 60,113,000 | 55,643,000 | 55,094,000 | 58,497,000 | 68,538,000 | 77,944,000 | 92,952,000 | 100,331,000 | 99,879,000 | 101,335,000 | 92,570,000 | 81,491,000 | 69,337,000 | 57,374,000 | 50,198,000 | 47,644,000 | 48,648,000 | 49,197,000 | 50,660,000 |
| Property, plant and equipment | US$ in thousands | — | — | — | 18,803,000 | 21,864,000 | 17,862,000 | 17,488,000 | 17,052,000 | 16,274,000 | 15,441,000 | 15,244,000 | 15,109,000 | 14,882,000 | 14,436,000 | 14,224,000 | 14,011,000 | 13,900,000 | 14,403,000 | 14,113,000 | 14,040,000 |
| Fixed asset turnover | — | — | — | 2.93 | 2.68 | 3.84 | 4.46 | 5.45 | 6.17 | 6.47 | 6.65 | 6.13 | 5.48 | 4.80 | 4.03 | 3.58 | 3.43 | 3.38 | 3.49 | 3.61 |
December 31, 2024 calculation
Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $63,627,000K ÷ $—K
= —
The fixed asset turnover ratio for Pfizer Inc has shown a fluctuating trend over the past few years. From March 31, 2020, to December 31, 2020, the ratio ranged between 3.38 to 3.61, indicating that the company generated approximately $3.38 to $3.61 in revenue for every dollar invested in fixed assets during that period.
Thereafter, the fixed asset turnover ratio experienced a significant improvement, reaching a peak of 6.65 on June 30, 2022, and remaining relatively high until March 31, 2023. This suggests that Pfizer was able to utilize its fixed assets more efficiently to generate revenue during this period.
However, the ratio saw a decline from June 30, 2023, to December 31, 2023, dropping to as low as 2.68. This decrease indicates a potential decrease in the company's ability to generate revenue from its fixed assets efficiently.
As of March 31, 2024, the fixed asset turnover ratio rebounded slightly to 2.93, showing some improvement from the previous quarter. It is worth noting that the data for the following quarters, from June 30, 2024, onwards, is not available.
Overall, despite some fluctuations, Pfizer Inc has demonstrated variations in its ability to generate revenue from its fixed assets efficiently over the period covered by the data.
Peer comparison
Dec 31, 2024